DNA immunotherapeutics: New potential treatment modalities for allergic disease

International Archives of Allergy and Immunology

Volumn 116, Issue 3, 1998, Pages 177-187

  Goodman, Justin S ^a   Van Uden, John H ^a,b   Kobayashi, Hiroko ^a   Broide, David ^a   Raz, Eyal ^a  

^a San Diego   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Allergy, prevention and treatment; CpG; DNA immunotherapeutics; Genetic vaccination; Immunostimulatory DNA sequences; Th1

Indexed keywords

IMMUNOMODULATING AGENT;

ALLERGIC DISEASE; DNA SEQUENCE; GENE THERAPY; HELPER CELL; IMMUNIZATION; IMMUNOSTIMULATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; ANTIGENS; EOSINOPHILIA; HUMANS; HYPERSENSITIVITY; IMMUNOTHERAPY; PULMONARY EOSINOPHILIA; TH1 CELLS; TH2 CELLS; VACCINES, DNA;

EID: 0031872504     PISSN: 10182438     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023943     Document Type: Review

References (75)

1. Wolff JA, Malone RW, Williams P, et al: Direct gene transfer into mouse muscle in vivo. Science 1990;247:1465-1468.
2. Yang NS, Burkholder J, Roberts B, Martinell B, McCabe D: In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardmenl. Proc Natl Acad Sci USA 1990; 87:9568-9572.
3. Tang DC, De Vit M, Johnston SA: Genetic immunization is a simple method for eliciting an immune response. Nature 1992;356:152-154.
4. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL: DNA vaccines: Protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proc Natl Acad Sci USA 1993;90:11478-11482.
5. Fynan EF, Robinson HL, Webster RG: Use of DNA encoding influenza hemagglutinin as an avian influenza vaccine. DNA Cell Biol 1993; 12:785-789.
6. Robinson HL, Hunt LA, Webster RG: Protection against a lethal influenza virus challenge by immunization with a haemagglutinin-expressing plasmid DNA. Vaccine 1993;11:957-960.
7. Ulmer JB, Donnelly JJ, Parker SE, et al: Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 1993;259:1745-1749.
8. Wang B, Ugen KE, Srikantan V, et al: Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:4156-4160.
9. Raz E, Carson DA, Parker SE, et al: Intradermal gene immunization: The possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994; 91:9519-9523.
10. McDonnell WM, Askari FK: DNA vaccines. N Engl J Med 1996;334:42-45.
11. Donnelly JJ, Ulmer JB, Liu MA: Immunization with DNA: J Immunol Methods 1994; 176:145-152.
12. Cox GJ, Zamb TJ, Babiuk LA: Bovine herpesvirus I: Immune responses in mice and cattle injected with plasmid DNA. J Virol 1993; 67:5664-5667.
13. Xiang Z, Entl HC: Manipulation of the immune response to a plasmid-encoded viral antigen by coinoculation with plasmids expressing cytokines. Immunity 1995;2:129-135.
14. Davis HL, McCluskie MJ, Gerin JL, Purcell RH: DNA vaccine for hepatitis B: Evidence for immunogenicity in chimpanzees and comparion with other vaccines. Proc Natl Acad Sci USA 1996;93:7213-7218.
15. Hoffman SL, Doolan DL, Sedegah M, et al: Nucleic acid malaria vaccines. Current status and potential. Ann NY Acad Sci 1995;772: 88-94.
16. Tascon RE, Colston MJ, Ragno S, Stavropoulos E, Gregory D, Lowrie DB: Vaccination against tuberculosis by DNA injection. Nat Med 1996;2:888-892.
17. Geissler M, Gesien A, Tokushige K, Wands JR: Enhancement of cellular and humoral immune responses to hepatitis C virus core protein using DNA-based vaccines augmented with cytokine-expressing plasmids. J Immunol 1997;158:1231-1237.
18. Davis HL, Michel ML, Mancini M, Schleef M, Whalen RG: Direct gene transfer in skeletal muscle: Plasmid DNA-based immunization against the hepatitis B virus surface antigen. Vaccine 1994;12:1503-1509.
19. Donnelly JJ, Friedman A, Martinez D, et al: Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus. Nat Med 1995;1: 583-587.
20. Coney L, Wang B, Ugen KE, et al: Facilitated DNA inoculation induces anti-HIV-1 immunity in vivo. Vaccine 1994;12:1545-1550.
21. Waisman A, Ruiz PJ, Hirschberg DL, et al: Suppressive vaccination with DNA encoding a variable region gene of the T-cell receptor prevents autoimmune encephalomyelitis and activents Th2 immunity. Nat Med 1996;2:899-905.
22. Raz E, Tighe H, Sato Y, et al: Preferential induction of a Th1 immune response and inhibition of specific IgE antibody formation by plasmid DNA immunization. Proc Natl Acad Sci USA 1996;93:5141-5145.
23. Hsu CH, Chua KY, Tao MH, Huang SK, Hsieh KH: Inhibition of specific IgE response in vivo by allergen-gene transfer. Int Immunol 1996;8: 1405-1411.
24. Roman M, Spiegelberg HL, Broide D, Raz E: Gene immunization for allergic disorders. Springer Semin Immunopathol 1997;19:223-232.
25. Condon C, Watkins SC, Celluzzi CM, Thompson K, Falo LD Jr: DNA-based immunization by in vivo transfection of dentritic cells. Nat Med 1996;2:1122-1128.
26. Watanabe A, Raz E, Kohsaka H, et al: Induction of antibodies to a kappa V region by gene immunization. J Immunol 1993;151:2871-2876.
27. Geissler EK, Wang J, Fechner JH Jr, Burlingham WJ, Knechtle SJ: Immunity to MHC class I antigen after direct DNA transfer into skeletal muscle. J Immunol 1994;152:413-421.
28. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA: DNA vaccines. Annu Rev Immunol 1997;15: 617-648.
29. Wolff JA, Ludtke JJ, Acsadi G, Williams P, Jani A: Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992;1:363-369.
30. Corr M, Lee DJ, Carson DA, Tighe H, Gene vaccination with naked plasmid DNA: Mechanism of CTL priming. J Exp Med 1996;184: 1555-1560.
31. Streilein JW: Dermal cells: Underappreciated components of the skin associated lymphoid tissues (SALT); in Nickoloff BJ (ed): The Dermal Immune System. Boca Raton, CRC Press, 1993. pp 25-38.
32. Feltquate DM, Heaney S, Webster RG, Robinson HL: Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J Immunol 1997; 158:2278-2284.
33. Tighe H, Corr M, Roman M, Raz E: Gene vaccination: Plasmid DNA is more than just a blueprint. Immunol Today 1998;19:89-97.
34. Weller PF: Human eosinophils. J Allergy Clin Immunol 1997;100:283-287.
35. Broide D, Orozco EM, Roman M, Carson DA, Raz E: Intradermal gene vaccination down-regulates both arms of the allergic response (abstract). J Allergy Clin Immunol 1997;99:S129.
36. Corry DB, Folkesson HG, Warnock ML, et al: Interleukin 4, but not interleukin 5 or eosinophils. is required in a murine model of acute airway hyperreactivity. J Exp Med 1996;183: 109-117.
37. Hsu CH, Chua KY, Tao MH, et al: Immunoprophylaxis of allergen-induced immunoglobulin E synthesis and airway hyperresponsiveness in vivo by genetic immunization. Nat Med 1996;2:540-544.
38. Slater JE, Colberg-Poley A: A DNA vaccine for allergen immunotherapy using the latex allergen Hev b 5. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf AM 1997;91:235; discussion 235-236.
39. Lee DJ, Tighe H, Corr M et al: Inhibition of IgE antibody formation by plasmid DNA immunization is mediated by both CD4+ and CD8+ T cells. Int Arch Allergy Immunol 1997; 113:227-230.
40. Klinman DM, Yamshchikov G, Ishigatsubo Y: Contribution of CpG motifs to the immunogenicity of DNA vaccines. J Immunol 1997; 158:3635-3639.
41. Sato Y, Roman M, Tighe H, et al: Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-354.
42. Roman M, Martin-Orozco E, Goodman JS, et al: Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat Med 1997;3:849-854.
43. Tytell AA, Lampson GP, Field AK, Hilleman MR: Inducers of Interferon and host resistance. 3. Double-stranded RNA from reovirus type 3 virions (reo 3-RNA). Proc Natl Acad Sci USA 1967;58:1719-1722.
44. Lampson GP, Tytell AA, Field AK, Nemes MM, Hilleman MR: Inducers of interferon and host resistance. I. Double-stranded RNA from extracts of Penicillium funiculosum. Proc Natl Acad Sci USA 1967;58:782-789.
45. Zilberstein A, Kimchi A, Schmidt A, Revel M: Isolation of two interferon-induced translational inhibitors: A protein kinase and an oligo-isoadenylate synthetase. Proc Natl Acad Sci USA 1978;75:4734-4738.
46. Meurs E, Chong K, Galabru J, et al: Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell 1990;62:379-390.
47. Messina JP, Gilkeson GS, Pisetsky DS: The influence of DNA structure on the in vitro stimulation of murine lymphocytes by natural and synthetic polynucleotide antigens. Cell Immunol 1993;147:148-157.
48. Messina JP, Gilkeson GS, Pisetsky DS: Stimulation of in vitro murine lymphocyte proliferation by bacterial DNA. J Immunol 1991;147: 1759-1764.
49. Tokunaga T, Yamamoto H, Shimada S, et al: Antitumor activity of deoxyribonucleic acid fraction from Mycobacterium bovis BCG. I. Isolation, physicochemical characterization, and antitumor activity. J Natl Cancer Inst 1984; 72:955-962.
50. Shimada S, Yano O, Tokunaga T: In vivo augmentation of natural killer cell activity with a deoxyribonucleic acid fraction of BCG. Jpn J Cancer Res 1986;77:808-816.
51. Tokunaga T, Yano O, Kuramoto E, et al: Synthetic oligonucleotides with particular base sequences from the cDNA encoding proteins of Mycobacterium bovis BCG induce interferons and activate natural killer cells. Microbiol Immunol 1992;36:55-66.
52. Kataoka T, Yamamoto S, Yamamoto T et al: Antitumor activity of synthetic oligonucleotides with sequences from cDNA encoding proteins of Mycobacterium bovis BCG. Jpn J Cancer Res 1992;83:244-247.
53. Yamamoto S, Yamamoto T, Kataoka T, Kuramoto E, Yano O, Tokunaga T: Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN and augment IFN-mediated natural killer activity. J Immunol 1992;148:4072-4076.
54. Kuramoto E, Yano O, Kimura Y, et al: Oligonucleotide sequences required for natural killer cell activation. Jpn J Cancer Res 1992; 83:1128-1131.
55. Sonehara K, Saito H, Kuramoto E, Yamamoto S, Yamamoto T, Tokunaga T: Hexamer palindromic oligonucleotides with 5′-CG-3′ motif(s) induce production of interferon. J Interferon Cytokine Res 1996;16:799-803.
56. Krieg AM: CpG DNA: A pathogenic factor in systemic lupus erythematosus? J Clin Immunol 1995;15:284-292.
57. Ballas ZK, Rasmussen WL, Krieg AM: Induction of NK activity in murine and human cells by CpG motifs in oligodeoxynucleotides and bacterial DNA. J Immunol 1996;157:1840-1845.
58. Yamamoto S, Yamamoto T, Shimada S, et al: DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiol Immunol 1992;36:983-997.
59. Yamamoto T, Yamamoto S, Kataoka T, Komuro K, Kohase M, Tokunaga T: Synthetic oligonucleotides with certain palindromes stimulate interferon production of human peripheral blood lymphocytes in vitro. Jpn J Cancer Res 1994;85:775-779.
60. Klinman DM, Yi AK, Beaucage SL, Conover J, Krieg AM: CpG motifs present in bacteria DNA rapidly induce lymphocytes to secrete interleukin 6, interleukin 12, and interferon gamma. Proc Natl Acad Sci USA 1996;93: 2879-2883.
61. Liang H, Nishioka Y, Reich CF, Pisetsky DS, Lipsky PE: Activation of human B cells by phosphorothioate oligodeoxynucleotides. J Clin Invest 1996;98(5):1119-1129.
62. Brinkmann V, Geiger T, Alkan S, Heusser CH: Interferon alpha increases the frequency of interferon gamma-producing human CD4+ T cells. J Exp Med 1993;178:1655-1663.
63. Bradley LM, Dalton DK, Croft M: A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol 1996;157:1350-1358.
64. Okamura H, Tsutsi H, Komatsu T, et al: Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 1995; 378:88-91.
65. Trinchieri G: Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995;13:251-276.
66. Yaegashi Y, Nielsen P, Sing A, Galanos C, Freudenberg MA: Interferon beta, a cofactor in the interferon gamma production induced by gram-negative bacteria in mice. J Exp Med 1995;181:953-960.
67. Kimura Y, Sonehara K, Kuramoto E, et al. Binding of oligoguanylate to scavenger receptors is required for oligonucleotides to augment NK cell activity and induce IFN. J Biochem (Tokyo) 1994;116:991-994.
68. Chu RS, Targoni OS, Krieg AM, Lehmann PV, Harding CV: CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) Immunity. J Exp Med 1997;186:1623-1631.
69. Davis HL, Michel ML, Whalen RG: DNA-based immunization induces continuous secretion of hepatitis B surface antigen and high levels of circulating antibody. Hum Mol Genet 1993;2:1847-1851.
70. Noon L, Prophylactic inoculation against hayfever. Lancet 1911;i1:1572-1573.
71. Lowell FC, Franklin W: A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever. N Engl J Med 1965;273:675-679.
72. Weber RW: Immunotherapy with allergens. JAMA 1997;278:1881-1887.
73. Barnes PJ: Is immunotherapy for asthma worthwhile? N Engl J Med 1996;334: 531-532.
74. Lin MS, Tanner E, Lynn J, Friday GA Jr Non-fatal systemic allergic ractions induced by skin testing and immunotherapy. Ann Allergy 1993; 71:557-562.
75. Reid MJ, Lockey RF, Turkeltaub PC, Platts-Mills TA: Survey of fatalities from skin testing and immunotherapy 1985-1989. J Allergy Clin Immunol 1993;92:6-15.